XOMA-Logo-Final.png
XOMA to Present At the Jefferies Healthcare Conference On June 26
June 19, 2008 16:35 ET | XOMA Corporation
BERKELEY, Calif., June 19, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief...
XOMA-Logo-Final.png
XOMA 052 Demonstrates Anti-Inflammatory Effect in Arthritis Animal Studies; Data Presented At FOCIS
June 07, 2008 14:00 ET | XOMA Corporation
SAN FRANCISCO, June 7, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) announced today at the Federation of Clinical Immunology Societies 2008 FOCIS Annual Meeting that a study of XOMA 052 in a mouse...
XOMA-Logo-Final.png
XOMA 052 Demonstrates Anti-Inflammatory Effects in Diabetes Animal Studies; Data Presented At ADA
June 07, 2008 13:00 ET | XOMA Corporation
SAN FRANCISCO, June 7, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) announced today at the American Diabetes Association's 68th Scientific Sessions that a study of XOMA 052, a potent...
XOMA-Logo-Final.png
XOMA to Present At the Needham Biotechnology and Medical Technology Conference On June 11
June 05, 2008 16:35 ET | XOMA Corporation
BERKELEY, Calif., June 5, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief...
XOMA-Logo-Final.png
XOMA to Present At the Rodman and Renshaw Global Healthcare Conference On May 20
May 14, 2008 16:35 ET | XOMA Corporation
BERKELEY, Calif., May 14, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that David Boyle, Vice President of...
XOMA-Logo-Final.png
XOMA Reports First Quarter 2008 Financial Results
May 12, 2008 06:06 ET | XOMA Corporation
BERKELEY, Calif., May 12, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced its results for the quarter ended March...
XOMA-Logo-Final.png
XOMA Refinances Royalty-Based Loan Facility for $55 Million
May 12, 2008 06:05 ET | XOMA Corporation
BERKELEY, Calif., May 12, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that it has entered into an amended loan...
XOMA-Logo-Final.png
XOMA to Announce First Quarter 2008 Financial Results and Host Conference Call on Monday, May 12
May 05, 2008 08:05 ET | XOMA Corporation
BERKELEY, Calif., May 5, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced that the Company will host a conference call...
XOMA-Logo-Final.png
XOMA Announces New Audit Committee Member
April 01, 2008 17:30 ET | XOMA Corporation
BERKELEY, Calif., April 1, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA) announced today that XOMA's Board of Directors has appointed Board member William K. Bowes, Jr. to its Audit Committee. The...
XOMA-Logo-Final.png
XOMA to Present At Cowen Health Care Conference On March 17
March 12, 2008 17:05 ET | XOMA Corporation
BERKELEY, Calif., March 12, 2008 (PRIME NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief...